Navigation Links
Amnis Begins Shipment of New ImageStreamX Imaging Flow Cytometers

SEATTLE, Oct. 6 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the first commercial shipments of the new ImageStreamX imaging flow cytometers. The new instrument - the second generation of Amnis' patented ImageStream® technology - combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery, rich feature set, and functional insights of microscopy.

"The ImageStreamX is the result of focused technology development based on both a broad market research study and more than five years of very close work with our customer base," remarked William E. Ortyn, Amnis' co-founder and Chief Operating Officer. "If early market response is a good indicator of ultimate product success, then it appears this work was right on the mark," he added.

"Pre-sales of the ImageStreamX have greatly exceeded our expectations, particularly given the current economic climate," said David Basiji, Ph.D., Amnis' President and Chief Executive Officer. "These sales results are due to the dramatic performance increase combined with the greater affordability and modularity of the new ImageStreamX, which allows the instrument to fit into a much wider range of labs and budgets," explained Basiji. Mr. Ortyn added, "The ImageStreamX has many of the attributes necessary to perform in the clinical market place. Over the next several months we look forward to releasing a wide array of options and applications kits to further enhance product capabilities."

About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets. The initial ImageStream system, introduced in 2005, is in service in over 15 countries world-wide, and has an excellent track record of performance and reliability. Researchers have utilized ImageStream technology to produce over 80 groundbreaking publications and numerous conference posters and presentations.

SOURCE Amnis Corporation

SOURCE Amnis Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
2. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
8. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
11. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
Post Your Comments:
(Date:10/13/2015)... China Jo-Jo Drugstores, Inc. (NASDAQ ... a leading China-based retail, wholesale and online distributor of ... and retail pharmacies, announced preliminary half year fiscal 2016 ... through , growing 438% year over year, ... China Jo-Jo,s online sales are principally ...
(Date:10/13/2015)...  XiMo AG ( Lucerne , ... Milpitas, California ) announced today the launch ... importance of metathesis chemistry was highlighted by the Nobel ... application. This industrially-relevant application has been utilized in the ... chemicals, and polymers. Georg Fráter , COO ...
(Date:10/12/2015)... -- Apheresis is an invasive process that ... and other components from whole blood. In this procedure, the ... an apheresis machine or a blood cell separator. The apheresis ... other blood components. A selected part of the blood is ... or the patient. It involves the use of devices and ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... "My friend's son suffers from eczema, and ... cheeks," said an inventor from Platteville, Colo. "I came up with this kit as ... the UNTOUCHABLE to prevent a child from rubbing or scratching his or her face. ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... platform, ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a technology ... innovative health programs and interventions via mobile devices that provide a framework for ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... solutions, announced today their sponsorship of the Microsoft Dynamics AXUG, GPUG and NAVUG ... Summit, GPUG Summit and NAVUG Summit are independent user conferences designed and led ...
(Date:10/13/2015)... ... 2015 , ... In an age where the cost of energy is rising, ... foot than in 2009. The Williamsport Regional Medical Center (WRMC) campus has grown 50 ... eight percent. , According to Facilities Management Administrative Director Dieter Reichmann, this is ...
(Date:10/13/2015)... ... 2015 , ... e-con Systems Inc., a leading embedded design services company specializing ... first RGB-IR pixel format camera with a USB 3.0 interface and e-CAM40_CUMI4682_MOD, ... UVC USB 3.0 cameras, is based on the 1/3-inch OV4682 - a 4-megapixel image ...
Breaking Medicine News(10 mins):